Introduction 1
scores with more severe impairments amongst those with prominent psychosis and 25 fewer affective symptoms. However, findings from neuropsychological studies of 26 these three disorders have been inconsistent with some studies indicating that 27 performance in schizoaffective disorder is similar to schizophrenia 13 and others 28 indicating no differences between diagnostic groups [14] [15] [16] [17] . 29
There are a number of potential explanations for the conflicting findings between 30 studies including differences in the use of covariates and the phase of illness of the 31 study participants. Studies of symptomatic participants with schizophrenia, 32 schizoaffective disorder and bipolar disorder have reported similar levels of 33 impairment 15, 16 . It has been argued that cognitive impairments are state dependent 34 in bipolar disorder and therefore improve during periods of remission. However, 35 more recent research has demonstrated that cognitive impairments are present in 36 euthymic bipolar disorder 18 . Lifetime history of psychosis in bipolar disorder has 37 been identified as another important factor that may influence cognitive function. 38
Studies do not consistently report the proportion of participants with bipolar 39 disorder who have a lifetime history of psychosis despite evidence that the presence 40 or absence of lifetime psychosis differentiates participants with cognitive 41 impairments from those without impairments 17 . Finally, studies often consider 42 schizoaffective disorder as a single group but there is little data to indicate whether 43 differences exist between the subtypes of schizoaffective disorder (depressive or 44 bipolar). The study by Hill et al. 10 showed greater overall impairment in participants 45
with the depressive subtype of schizoaffective disorder than the bipolar subtype, 46 although the differences were not significant. Two smaller studies found no 47 differences between participants with the depressive subtype and participants withschizophrenia but did not consider the bipolar subtype 14, 19 . This suggests 49 amalgamation of both subtype of schizoaffective disorder as a single group may 50 obscure findings. To our knowledge, there have been no published studies that have 51 compared the subtypes of schizoaffective disorder individually to schizophrenia and 52 bipolar disorder. 53
The aim of this study was to test the hypothesis that there is a spectrum of 54 increasing cognitive impairment from bipolar disorder through schizoaffective 55 bipolar to schizoaffective depressive and schizophrenia. We also hypothesised that 56 lifetime frequency and severity of psychotic symptoms (across and within diagnostic 57 boundaries) would be associated with cognitive impairment. These hypotheses were 58 tested in three ways. Firstly, we compared cognitive performance between the 59 diagnostic groups. Secondly, we examined whether cognition can be considered a 60 continuous measure across disorders. For this analysis, the schizophrenia and 61 schizoaffective depressive groups were combined into a single group based on pre-62 existing data suggesting that performance between these groups is equivalent 10, 14, 63 19 . Thirdly, we examined whether cognitive performance is associated with 64 symptoms domains across diagnostic groups. 65
Methods

67
Participants 68
Participants were recruited as part of the Cognition in Mood, Psychosis and 69 Schizophrenia Study (COMPASS), a UK based study that recruits from outpatient 70
clinics. This sample includes participants previously referred to as the Cardiff 71
Cognition in Schizophrenia (COGS) sample (described elsewhere in 20 ). All patient 72 groups were recruited as part of a single study and all aspects of recruitment,response rates, phenotyping and determining diagnosis were equivalent across 74 groups. Participants were interviewed using the Schedules for Clinical Assessment in 75 Neuropsychiatry (SCAN) 21 . This interview was reviewed along with available clinical 76 records by trained raters to determine a consensus lifetime DSM-IV diagnosis 22 
77
(inter-rater reliability Kappa statistics: schizophrenia=0.83, schizoaffective 78 depressive=0.63, schizoaffective bipolar=0.72, bipolar disorder=0.85). The final 79 sample included 824 participants with a diagnosis of schizophrenia (N=558), 80 schizoaffective depressive (N=112), schizoaffective bipolar (N=76) or bipolar disorder 81 (N=78). The bipolar disorder group included all participants who met criteria for a 82 diagnosis of bipolar disorder -type I (N=68) or type II (N=10), of which 59 had a 83 lifetime history of psychosis. Participants were excluded if they suffered from a 84 neurological condition that was likely to impact their ability to participate in the 85 study or had a current substance dependence disorder. 86
One hundred and three control participants were recruited from the community and 87 completed the Mini International Neuropsychiatric Interview (MINI) 23 as a screen 88 for mental disorders. Controls were excluded if they met criteria for schizophrenia or 89 bipolar disorder or there was a family history of these conditions. All participants 90 provided written informed consent and were reimbursed for their participation. 24 ). This battery was designed specifically for use in schizophrenia research 98 but has been shown to be a valid and reliable cognitive measure in bipolar disorder 99 [25] [26] [27] . The MCCB measures seven domains of cognition using ten tasks: 100 
Comparing cognition between diagnostic groups 131
Statistical analyses to compare the groups were performed using R version 3.1.2. For 132 each cognitive domain and across diagnostic groups, performance was compared 133 using analysis of covariance with age and sex as covariates and followed up with 134
Tukey's H"D for pair ise o pariso s. Bo ferro i orre tio as used to adjust for 135 multiple comparisons resulting in an alpha of 0.00625 (0.05/8, 7 domains and 136 composite score). The alpha was not corrected further for the number of pairwise 137 o pariso s, as Tukey's H"D is already a o ser ati e test that orre ts for fa ily-138 ise error rate. Cohe 's d ere al ulated y di idi g ea group differe e y the 139 pooled standard deviation and used as a measure of effect size. 34 Repeated 140 measures analysis of variance was used to compare profiles of cognitive 141 performance between groups. The within-subject factor was cognitive domain. The 142 effects of medication and symptoms as potential confounding variables were 143 investigated by including olanzapine equivalent dose, duration of antipsychotic 144 exposure, SAPS total scores, SANS total scores, BADDS lifetime depression, 145 educational attainment and parental occupation as covariates. 146
Examining cognition as a dimension across diagnostic groups 147
To test our hypothesis that cognition can be considered a dimensional phenotype 148
showing increasing impairment from bipolar disorder to schizoaffective bipolar to 149 schizophrenia and schizoaffective depressive combined, we conducted an ordinal 150 regression using SPSSv.22 with diagnosis as the outcome, composite cognition score 151 as the predictor and age and sex as covariates. Schizophrenia and schizoaffective 152 depressive were combined given pre-existing data indicating that their degree of 153 impairment is comparable 10, 14, 19 . Diagnosis was coded on an ordinal scale 154 combining schizoaffective depressive and schizophrenia: 0 -schizoaffective 155 depressive and schizophrenia, 1 -schizoaffective bipolar, 2 -bipolar disorder. 156
Cross disorder symptom dimensions and cognitive performance 157
Finally, each BADDS dimension was entered into separate linear regressions as 158 predictors with composite cognition as the outcome using R version 3.1.2. This was 159 initially done across the whole sample and then separately for bipolar disorder / 160 schizoaffective bipolar and schizophrenia / schizoaffective depressive. 161
Results
163
Demographic and clinical variables 164
Demographic and clinical variables are displayed for each diagnostic group in Table  165 1. Groups differed in proportion of males (χ 2 =61.39, p<0.001) with more males 166 observed in the schizophrenia group therefore sex was used as a covariate in all 167
analyses. There were differences in estimated premorbid IQ (F=22.64, p<0.001) and 168 years in education (F=14. 19 Effect sizes for each pairwise comparison between diagnoses for all domains are 183 displayed in Figure 2 . All diagnostic groups were impaired compared to controls 184 across cognitive domains with the exception of social cognition in those with bipolar 185 disorder. The bipolar disorder group was the least impaired of the diagnostic groups, 186 performing 0.5 to 1.25 standard deviations below the mean of the control group 187 across domains (composite cognition: d=1.12, p<0.001). Although the groups were 188 small, we compared bipolar disorder -type I (N=68) and bipolar disorder -type II 189 (N=10) and found no significant differences between these groups (composite 190 cognition: d=-0.07, p=0.83, see supplementary domains. Current psychotic symptoms (SAPS score) were not associated with 233 performance across domains, other than social cognition. The analyses were also 234 repeated including educational attainment and parental occupations (as measures of 235 socioeconomic status) and the effect of diagnosis on cognition remained significant 236 (supplementary table S9 ). Finally, diagnosis, olanzapine equivalent dose, duration of 237 antipsychotic exposure, total SANS scores, total SAPS scores and lifetime depression 238 (as measured by the BADDS depression scale) were added as predictors into a single 239 model. The main effect of diagnostic group on composite cognition remained 240 domains). After correction for multiple testing, there were significant differences in 242 composite cognition scores between schizoaffective depressive and bipolar disorder 243 (d=0.65, p<0.001) and schizophrenia and bipolar disorder (d=0.58, p<0.001). The 244 relative contributions of each covariate can be found in supplementary table S11. 245
Examining cognition as a dimension across diagnostic groups 246
We used ordinal regression to test whether cognition can be considered a 247 dimensional phenotype across the diagnostic spectrum. This analysis indicated that 248 higher cognitive scores were associated with higher scores on the diagnostic scale 249 We set out to test the hypothesis that there is a spectrum of increasing cognitive 292 impairment from bipolar disorder to schizophrenia and schizoaffective depressive. 293
We report that whilst cognitive profiles were similar across disorders, these 294 impairments increased in severity from bipolar disorder to schizoaffective bipolar to 295 schizophrenia and schizoaffective depressive. There were no differences between 296 schizophrenia and schizoaffective depressive in severity of cognitive impairments. 297
Differences between the groups were not explained by differences in antipsychotic 298 medication or current positive and negative symptoms. In accordance with our 299 hypothesis, ordinal regression modelling provided support for a gradient of 300 increasing cognitive impairment across disorders. Finally we found that higher scores 301 on the BADDS psychosis dimension, a measure of the severity and frequency of 302 lifetime psychosis, were associated with lower cognitive scores. 303
Performance across the cognitive domains was equivalent in the schizophrenia and 304 schizoaffective depressive groups. These results suggest that from a cognitive 305 perspective, there is questionable validity in the nosological distinction between 306 schizophrenia and schizoaffective depressive. Therapies developed to improve 307 cognition in schizophrenia should also be targeted towards patients with 308 schizoaffective depressive type. These findings also highlight the importance of 309 considering the subtypes of schizoaffective disorder separately, as these groups 310 differed in severity of cognitive impairments. 311 Differences in overall cognition between schizoaffective bipolar and bipolar disorder 312
were not significant after correction for multiple testing. However, the effect size 313 between these groups (d=0.44) was larger than that observed between 314 schizophrenia and schizoaffective depressive (d=0.07). This may explain why a linear 315 trend from bipolar disorder to schizoaffective bipolar to schizophrenia and 316 schizoaffective depressive was still observed in the ordinal regression analysis. We 317 used a conservative Bonferroni-corrected alpha value to control the type-I error rate 318 but at the cost of loss of power, which could explain the lack of significant 319 difference. However, it should be noted that there were smaller differences between 320 schizoaffective bipolar and bipolar disorder on individual domains, which were not 321 significant even at alpha=0.05. 322
Diagnostic groups were differentiated on the basis of severity of cognitive 323 impairments but the overall pattern of impairment was similar between the groups 324 (Fig. 1) . This suggests cognitive impairment can be considered a dimensional 325 phenotype that cuts across diagnostic boundaries. These results are consistent with 326 the results of previous studies showing that multiple domains of cognition are 327 affected and these impairments increase in severity from bipolar disorder to 328 schizophrenia [9] [10] [11] [12] . Similarities between the cognitive profiles of these disorders are 329 consistent with a shared underlying neurobiology that differs quantitatively rather 330 than qualitatively across the diagnostic groups 1, 7, 8 . Indeed, previous studies have 331 indicated overlap in regions of grey matter reduction (though less consistently in 332 bipolar disorder) [35] [36] [37] [38] and genetic susceptibility [39] [40] [41] [42] . 333
Whilst neurocognitive impairments were evident across all diagnoses, impairments 334 in social cognition were not present in bipolar disorder but were observed in 335 schizophrenia and schizoaffective disorder. The largest difference between 336 participants with schizoaffective bipolar and bipolar disorder was observed in social 337 cognition suggesting there may be some distinction in the cognitive processes 338 underlying these disorders despite similar neurocognitive profiles. Social cognition 339 was the only domain associated with current positive symptoms. Previous studies 340 have demonstrated associations between domains of social cognition, particularly 341 theory of mind deficits, and psychotic symptoms in schizophrenia [43] [44] [45] . These results 342 suggest that certain social cognitive tasks may differentiate bipolar disorder from 343 other disorders within the bipolar disorder / schizophrenia spectrum. The 344 association between social cognitive impairment and psychosis provides support for 345 cognitive models of psychosis that posit a role for social interpretations in the 346 development of psychotic thinking 46 . 347
Lifetime history of psychosis, as measured by the BADDS psychosis dimension, was 348 associated with cognitive performance in our cross-diagnostic analysis. The BADDS 349 psychosis dimension measures the prominence of psychotic symptoms over the 350 course of illness and considers both duration and number of psychotic episodes. 351
Lifetime history of psychosis has been shown to be associated with poorer 352 cognition 17 . Our results expand on these findings by using a dimensional approach to 353
show that lifetime frequency and severity of psychosis predicts severity of cognitive 354
impairments. 355
This study has several strengths. It is one of the largest samples to date and is of a 356 sufficient size to allow us to separate the subtypes of schizoaffective disorder. The 357 sample is well characterised with consensus lifetime diagnoses based on semi-358 structured interview and medical records. The clinical characterisation of the sample 359 allowed us to adjust for the effects of current symptoms and antipsychotic 360 medication, including both current and lifetime antipsychotic exposure. 361
Limitations 362
A number of limitations should be noted. The sizes of the diagnostic groups were 363 uneven and there was a larger sample of participants with schizophrenia than the 364 other disorders. Despite this, our analyses were robust to differences in the group 365 sizes and we were able to detect differences between groups. Our bipolar disorder 366 group consisted of a mixture of patients with and without a lifetime history of 367 psychosis. Given the small number of participants without psychosis, it was not 368 possible to separate the bipolar group into those with and without history of 369 psychosis to examine differences between these groups and schizophrenia or 370 schizoaffective disorder. The MCCB was designed for use with participants with 371 schizophrenia. Previous studies of bipolar disorder have failed to find deficits in 372 executive functioning using the NAB Mazes task 25, 27, 47 . The authors of these studies 373 note that more complex measures of executive function, such as the Wisconsin Card 374
Sorting Task, may be more sensitive to detecting deficits in bipolar disorder. 375
Although our bipolar group was impaired on the NAB Mazes relative to controls, this 376 task may not have been sufficiently complex to differentiate bipolar disorder and 377 schizoaffective disorder -bipolar type. Furthermore, our bipolar group was not 378 impaired on the social cognition task (MSCEIT) but previous studies have identifieddeficits in theory of mind and emotion recognition suggesting that patients with 380 bipolar disorder do have impairments in specific domains of social cognition 48, 49 . 381
Conclusion 382
Using a large and well-characterised sample, we have demonstrated that there is a 383 gradient of increasing cognitive impairment from bipolar disorder to schizoaffective 384 bipolar to schizophrenia and schizoaffective depressive. Differences in cognitive 385 profiles between the diagnoses were quantitative rather than qualitative. Our 386 findings comparing cognition between diagnostic groups confirmed our a priori 387 decision to combine participants with schizophrenia and schizoaffective depressive 388 in the subsequent analyses. This argues against separating schizophrenia and 389 schizoaffective depressive for such analyses. This study was also the first to use a 390 regression model to demonstrate a gradient of cognitive impairment and show that 391 a dimensional measure of lifetime psychotic episodes is linearly associated with 392 cognition. These results provide support for a model of psychotic and affective 393 disorders where diagnostic criteria focus on dimensional measures of symptoms 394 rather than traditional diagnostic categories. 395 Tables   Table 1 Demographic 
